Legal Representation
Attorney
Brent R. Bellows
USPTO Deadlines
Next Deadline
1211 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230523)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 23, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 23, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 31, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 20, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 12, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development in the field of of gene therapy, namely, the research and development of gene therapy pharmaceutical compositions for use in treating genetic disorders in human patients by targeting gene insertion into the liver
First Use Anywhere:
Sep 9, 2021
First Use in Commerce:
Sep 9, 2021
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MUTATION-AGNOSTIC IN VIVO GENE INSERTION"